Hester Biosciences Limited (BOM:524669)
India · Delayed Price · Currency is INR 2,351.55
-68.00 (-2.81%)
At close: Nov 6, 2026
Hester Biosciences Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 3,453 | 3,341 | 3,125 | 3,112 | 2,782 | 2,466 |
Revenue Growth | 14.51% | 6.93% | 0.41% | 11.86% | 12.80% | 13.30% |
Gross Profit Gross Profit Growth | 2,605 | 2,465 | 2,196 | 2,115 | 1,957 | 1,788 |
Operating Income Operating Income Growth | 757.52 | 692.99 | 456.22 | 431.29 | 420.28 | 550.43 |
Net Income Net Income Growth | 1,421 | 556.39 | 274.88 | 188.89 | 266.27 | 393.2 |
Earnings Per Share EPS Growth | 165.11 | 65.40 | 32.31 | 22.20 | 31.30 | 46.22 |
EPS Growth | 230.13% | 102.41% | 45.52% | -29.06% | -32.28% | 14.20% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Poultry Healthcare Poultry Healthcare Growth | 2,060 | 1,675 | 1,453 | 1,413 | 1,718 |
Animal Healthcare Animal Healthcare Growth | 1,266 | 1,436 | 1,325 | 1,141 | 631.75 |
Total Total Growth | 3,326 | 3,111 | 3,045 | 2,661 | 2,350 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 272.37 | 65.38 | 72.19 | 153.04 | 148.17 | 252.03 |
Total Debt Total Debt Growth | 1,085 | 1,948 | 2,133 | 2,577 | 2,742 | 2,282 |
Net Cash (Debt) Net Cash Growth | -812.81 | -1,883 | -2,060 | -2,424 | -2,593 | -2,030 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -94.45 | -221.30 | -242.19 | -284.99 | -304.85 | -238.59 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 956.63 | 641.41 | 645.11 | 481.83 | 235.96 | 87.12 |
Capital Expenditures CapEx Growth | -136.63 | -178.28 | -205.91 | -243.97 | -777.62 | -957.1 |
Free Cash Flow Free Cash Flow Growth | 820 | 463.13 | 439.2 | 237.86 | -541.66 | -869.98 |
Free Cash Flow Growth | 95.70% | 5.45% | 84.65% | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 75.45% | 73.76% | 70.29% | 67.95% | 70.35% | 72.50% |
Operating Margin | 21.94% | 20.74% | 14.60% | 13.86% | 15.11% | 22.32% |
Pretax Margin | 48.29% | 22.70% | 12.66% | 10.27% | 14.43% | 21.69% |
Profit Margin | 41.15% | 16.65% | 8.80% | 6.07% | 9.57% | 15.94% |
FCF Margin | 23.75% | 13.86% | 14.06% | 7.64% | -19.47% | -35.27% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 11.000 | 11.000 | 7.000 | 6.000 | 8.000 | 10.000 |
Dividend Per Share Growth | 57.14% | 57.14% | 16.67% | -25.00% | -20.00% | 0% |
Dividend Yield | 0.47% | 0.87% | 0.56% | 0.43% | 0.53% | 0.37% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 8, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 14.24 | 19.31 | 38.81 | 62.57 | 48.58 | 58.75 |
Forward PE | - | 39.50 | 39.50 | 39.50 | 32.93 | 53.45 |
P/FCF Ratio | 24.40 | 23.19 | 24.29 | 49.69 | - | - |
PS Ratio | 5.79 | 3.22 | 3.41 | 3.80 | 4.65 | 9.37 |